A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 269
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 52
Diseases Analyzed
2025 Cornea Products Market Report: Global Analysis for 2024 to 2030, December, 2025
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Latest Industry News & Trends
9/11/2026
BreakingCataractCornealRefractive
Bausch + Lomb Gains CE Marking for SeeLyra Femtosecond Laser
Bausch + Lomb reported Sept. 11 that its SeeLyra next-generation femtosecond laser had gained CE marking. The company said the SeeLyra, built on the Victus platform, is designed to provides surgeon...
9/11/2026
BreakingEuropeRetina
Oxford Eye Hospital Initiative Cuts IVT Injection Waste and Costs
Britain’s Oxford Eye Hospital reported Aug. 24 that an initiative there to change the way intravitreal (IVT) injections are administered has eliminated tons of associated single-use product waste a...
9/11/2026
BreakingCataractIOLMeeting
Rayner Launches Galaxy Hydrophobic Spiral IOL
UK-based Rayner reported Sept. 7 the launch of its Galaxy Hydrophobic spiral IOL at the 2026 ESCRS congress in London. The lens will be available commercially in the EU in Q4-2026. The original Gal...
9/11/2026
BreakingCataractEuropeIOLMeeting
Zeiss Announces Launch of AT Lucia Toric 721P
Zeiss Medical Technology reported Sept. 10 that it was launching its AT Lucia Toric 721P IOL at the 2026 ESCRS congress in London. Zeiss, of Germany, described the lens as the world's first hyd...
9/11/2026
BreakingCataractEuropeIOL
Alcon’s Clareon Monofocal Lens Gains MDR Certification, Expanded Labeling
Alcon reported Sept. 1 that it had gained MDR certification in the European Union for its Clareon Monofocal enhanced monofocal intraocular lens. The company noted that the hydrophobic acrylic lens ...
9/11/2026
EuropeGlaucomaRetina
UK Government Outlines Measures to Reduce Ophthalmology Waiting Times
The UK government on Aug. 25 outlined initiatives intended to reduce ophthalmology waiting times, address regional disparities, and move more eye care into community and digital settings. Gillian J...
9/11/2026
BreakingRetina
British Company Exonate Rebrands as Foventa Therapeutics
British company Exonate announced Sept. 1 that it had changed its name to Foventa Therapeutics. The company said its new name and motto “Simply Sharper” take inspiration from the fovea, the center ...
9/11/2026
BreakingClinical TrialCorneal
European Consortium Studies Gene-Silencing Eye Drops Targeting Corneal Vascularization
Two studies underway at the University of Cologne in Germany will test whether a new class of eye drops silencing the insulin-receptor substrate 1 (IRS1) gene can slow the blood vessel growth that ...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.